ISSUE #24 Feb 25, 2026
Editor's Note
As Lunar New Year has just passed,
we'd like to extend our warmest wishes for a healthy, happy, and successful 2026 💗
Catch the KoreaBIO team at these upcoming events:
🔹EW Biopharma Summit 2026 | March 9-11 | Seoul, Korea
🔹BIO Europe Spring 2026 | March 23-25 | Lisbon, Portugal
🔹BIO 2026 | June 22-25 | San Diego, CA, USA
🔹BIO Asia Taiwan 2026 | July 15-19 | Taipei, Taiwan
🔹BIOPLUS-INTERPHEX Korea 2026 | October 28-30 | Seoul, Korea
(...and stay tuned!)
We're looking forward to seeing you there🔥😎
▶ Notice
▶ Recent Events
▶ Latest News
What We've Been Up To
😥 Couldn’t join us in San Francisco?
Now’s your chance to see what you missed!
🤗 Were there?
Here's your quick encore!
Watch Now
What's Coming Up?
Top Stories
Inside Korea Bio
Here's what's happening across Korea's bio industry!
🚀 Korea Goes Global
∎ Korean Biopharma Ramps Up U.S. Production as Trump Tariff Uncertainty Grows - Aju Press
∎ D&D Pharmatech secures Russian, Canadian patents for oral peptide platform ‘Oralink’ - THE BIO
∎ GCCL expands global services through multinational clinical trials partnership with Europe’s MICS - THE BIO
∎ K-Bio Targets Global Biosimilar Market Amid Patent Expirations - Business Korea
∎ LigaChem strengthens ADC pipeline with new NovaRock licensing deal - KBR
∎ Samsung Bioepis finalizes global patent settlement for Eylea biosimilar - THE BIO
∎ Shaperon secures Australian composition patent for GPCR19-based next-generation inflammasome inhibitor - THE BIO
∎ Northwell Health Partners with Rokit Healthcare: What This Means for Skin Cancer Treatment in 2026 - News1
∎ ROKIT Healthcare breaks into Italy’s public health system with AI diabetic foot platform - KBR
∎ Lunit kicks off direct sales in Japan, expands Fujifilm pact to sharpen AI push - KBR
📈 Growth & Performance
∎ A wind of "transformation" is blowing in the domestic pharmaceutical, bio, and healthcare industries. - Maeil Business Newspaper
∎ Korea fast-tracks AI and bio startup patents to speed commercialization - Chosun Biz
∎ ImmuneOncia bets $83 million on rare cancer breakthrough - KBR
∎ Korean Firms Develop Topical/Injectable Hair Loss Treatments - The Chosun Ilbo
∎ Korean Obesity Drugs Target Year-End Launch - The Chosun Ilbo
∎ Korea to recognize pancreatic disorder as disability, raising stakes for CGM and pump reimbursement - KBR
∎ Unlocking Weight Loss: Hanmi Pharmaceutical's Innovative H.O.P Project and the Game-Changing Efpeglenatide - News1
∎ South Korean researchers identify brain circuit that senses salt levels to control intake - Aju Press
∎ South Korean scientists engineer microbe that thrives in toxic methanol - World Bio Market Insights
∎ Gene-edited weed efficiently produces key steroid drug precursor - DongA Science
∎ DuChemBio, Neurophet team up on AI-based PET platform to cut dementia test times - KBR
∎ Medical AI Revenue Surge Brings Korea Its First Profitable Listed Player - KoreaTechDesk
∎ Mobile Stethoscope App Detects Bronchitis, Pneumonia - The Chosun Ilbo
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부 Unsubscribe